Adenosine-Mediated Effects of Ticagrelor Evidence and Potential Clinical Relevance

被引:258
作者
Cattaneo, Marco [1 ]
Schulz, Rainer [2 ]
Nylander, Sven [3 ]
机构
[1] Univ Milan, Osped San Paolo, Dipartimento Sci Salute, Unita Med 3, I-20142 Milan, Italy
[2] Univ Giessen, Inst Physiol, D-35390 Giessen, Germany
[3] AstraZeneca Res & Dev, Molndal, Sweden
关键词
acute coronary syndrome(s); adenosine; antiplatelet agents; P2Y12; ticagrelor; ACUTE CORONARY SYNDROME; TARGETED DELETION; P2Y(12) RECEPTOR; A(3) RECEPTORS; INFARCT SIZE; PLATO TRIAL; CLOPIDOGREL; DYSPNEA; DIPYRIDAMOLE; MORTALITY;
D O I
10.1016/j.jacc.2014.03.031
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
This review constitutes a critical evaluation of recent publications that have described an additional mode of action of the P2Y(12) receptor antagonist ticagrelor. The effect is mediated by inhibition of the adenosine transporter ENT1 (type 1 equilibrative nucleoside transporter), which provides protection for adenosine from intracellular metabolism, thus increasing its concentration and biological activity, particularly at sites of ischemia and tissue injury where it is formed. Understanding the mode of action of ticagrelor is of particular interest given that its clinical profile, both in terms of efficacy and adverse events, differs from that of thienopyridine P2Y(12) antagonists. (c) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:2503 / 2509
页数:7
相关论文
共 60 条
[1]
Differential Effect of Ticagrelor Versus Prasugrel on Coronary Blood Flow Velocity in Patients With Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Exploratory Study [J].
Alexopoulos, Dimitrios ;
Moulias, Athanasios ;
Koutsogiannis, Nikolaos ;
Xanthopoulou, Ioanna ;
Kakkavas, Apostolos ;
Mavronasiou, Eleni ;
Davlouros, Periklis ;
Hahalis, George .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (03) :277-283
[2]
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease Results of the SWAP-2 Study (Switching Anti Platelet-2) [J].
Angiolillo, Dominick J. ;
Curzen, Nicholas ;
Gurbel, Paul ;
Vaitkus, Paul ;
Lipkin, Fred ;
Li, Wei ;
Jakubowski, Joseph A. ;
Zettler, Marjorie ;
Effron, Mark B. ;
Trenk, Dietmar .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (15) :1500-1509
[3]
[Anonymous], PLATELETS
[4]
Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1 [J].
Armstrong, Duncan ;
Summers, Claire ;
Ewart, Lorna ;
Nylander, Sven ;
Sidaway, James E. ;
van Giezen, J. J. J. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (02) :209-219
[5]
Regulation of Neutrophil Function by Adenosine [J].
Barletta, Kathryn E. ;
Ley, Klaus ;
Mehrad, Borna .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (04) :856-864
[6]
IONIC BASIS OF THE ELECTROPHYSIOLOGICAL ACTIONS OF ADENOSINE CARDIOMYOCYTES [J].
BELARDINELLI, L ;
SHRYOCK, JC ;
SONG, Y ;
WANG, D ;
SRINIVAS, M .
FASEB JOURNAL, 1995, 9 (05) :359-365
[7]
CARDIOVASCULAR EFFECTS OF ADENOSINE INFUSION IN MAN AND THEIR MODULATION BY DIPYRIDAMOLE [J].
BIAGGIONI, I ;
ONROT, J ;
HOLLISTER, AS ;
ROBERTSON, D .
LIFE SCIENCES, 1986, 39 (23) :2229-2236
[8]
TICAGRELOR, BUT NOT CLOPIDOGREL, PROTECTS THE HEART AND LIMITS MYOCARDIAL INFARCT SIZE [J].
Birnbaum, Yochai ;
Ling, Shukuan ;
Nanhwan, Manjyot K. ;
Kodakandla, Monica ;
Ye, Yumei .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) :A22-A22
[9]
Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome [J].
Bonello, Laurent ;
Laine, Marc ;
Kipson, Nathalie ;
Mancini, Julien ;
Helal, Olfa ;
Fromonot, Julien ;
Gariboldi, Vlad ;
Condo, Jocelyne ;
Thuny, Franck ;
Frere, Corinne ;
Camoin-Jau, Laurence ;
Paganelli, Franck ;
Dignat-George, Francoise ;
Guieu, Regis .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (09) :872-877
[10]
Blockade of airway sensory nerves and dyspnea in humans [J].
Burki, Naushervvan K. ;
Lee, Lu-Yuan .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (04) :279-282